03-08-2024On Wednesday as the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) was winding down, HIV.gov spoke with NIH s Dr. Carl Dieffenbach about...
NIAID
HIV Treatment Research and Key Takeaways: Dr. Dieffenbach’s Final Update from CROI 2024 Study Shows Promising Outcomes with HIV Treatment Started Promptly After Birth 03-07-2024On the final day of the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with Deborah Persaud, MD, Professor of Pediatrics at.…Long-Acting HIV Treatment Benefits Adults with Barriers to Daily Pill Taking and Adolescents with Suppressed HIV 03-06-2024Colorized transmission electron micrograph of two HIV-1 virus particles (red/yellow) budding from the plasma memb...Children Surpass a Year of HIV Remission after Treatment Pause 03-06-2024Colorized transmission electron micrograph of HIV-1 virus particles (yellow) budding and replicating from an H9...Addressing Liver and Cardiovascular Disease among People with HIV and HIV Prevention During Pregnancy: Dr. Dieffenbach’s Second Update from CROI 2024 03-06-2024On Tuesday at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with NIH s Dr. Carl Dieffenbach about research on common...Vaginal Ring and Oral Pre-Exposure Prophylaxis Found Safe for HIV Prevention Throughout Pregnancy 03-05-2024Transmission electron micrograph of HIV-1 virus particles (pink) replicating from the plasma membrane of an H9 T...Semaglutide Reduces Severity of Common Liver Disease in People with HIV 03-05-2024Cross-postedfrom:NIH Newsroom A weekly injection of semaglutide was safe and reduced the amount...Dr. LaRon Nelson on Community-Engaged Research, Future HIV Prevention Options, and More 03-05-2024At the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov caught up again with Dr. LaRon Nelson to discuss community-engaged resear...Doxy-PEP for STIs and HIV Vaccine Research: Dr. Dieffenbach’s First Update from CROI 2024 03-05-2024During the first full day of presentations at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), we spoke with NIH s Dr. Carl Dieffen...Tools Underestimate Cardiovascular Event Risk in People with HIV 03-04-2024Cross-posted from: NIH Newsroom The elevated cardiovascular disease risk among people with HIV is even grea...NIAID’s Dr. Jeanne Marrazzo Previews CROI 2024 03-04-2024HIV.gov opened our coverage of the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) today with a conversation with Jeanne Marrazzo, M.D.,...Follow HIV.gov Next Week: Key HIV Research Updates from CROI 2024 02-27-2024Next week, HIV.gov will be sharing updates on the latest HIV research from the 2024Conference on Retroviruses and Opportunistic Infections (CROI), taking...Statement: Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed 02-22-2024Cross-posted from: NIAID Newsroom Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine...Working Together to End HIV in Black Communities 02-07-2024Health inequities and disparities disproportionately affect Black people and other historically marginalized gro...Biomedical STI Prevention Evidence Is Inadequate for Cisgender Women 01-10-2024Note: As we continue to pursue the goals of both the STI National Strategic Plan and National HIV/AIDS Strateg...NIH Research Identifies Opportunities to Improve Future HIV Vaccine Candidates 12-20-2023Cross-posted from: NIAID Newsroom An effective HIV vaccine may need to prompt strong responses from immune...NIH Statement on World AIDS Day 2023 12-01-2023Cross-posted from: NIH Newsroom On this 35th World AIDS Day, the National Institutes of Health (NIH) joins its...NIH Statement on Preliminary Efficacy Results of First-in-Class Gonorrhea Antibiotic Developed Through Public-Private Partnership 11-14-2023Scanning electron micrograph of Neisseria gonorrhoeae bacteria, which causes gonorrhea. Captured by the Research...NIH Seeks Implementation Research Projects to Help End HIV 11-01-2023Cross-posted from: NIAID Funding News TheEnding the HIV Epidemic (EHE) in the U.S. initiativeis a b...The STOMP Trial Evaluates an Antiviral for Mpox 10-10-2023Cross-posted from:NIAID Newsroom Following a peak in the summer of 2022, new infections in the mpox clade IIb outbreak have decreased, due in part to the...